Copyright © 2010 Qian Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. B. R. Lucchesi and K. M. Mullane, “Leukocytes and ischemia-induced myocardial injury,” Annual Review of Pharmacology and Toxicology, vol. 26, pp. 201–224, 1986. View at Scopus
2. M. B. Forman, D. W. Puett, and R. Virmani, “Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications,” Journal of the American College of Cardiology, vol. 13, no. 2, pp. 450–459, 1989. View at Scopus
3. A. M. Lefer and D. J. Lefer, “The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion,” Cardiovascular Research, vol. 32, no. 4, pp. 743–751, 1996. View at Publisher · View at Google Scholar · View at Scopus
4. P. S. Tsao, N. Aoki, D. J. Lefer, G. Johnson III, and A. M. Lefer, “Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat,” Circulation, vol. 82, no. 4, pp. 1402–1412, 1990. View at Scopus
5. P. S. Tsao and A. M. Lefer, “Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts,” American Journal of Physiology, vol. 259, no. 6, part 2, pp. H1660–H1666, 1990.
6. P. R. Hansen, “Role of neutrophils in myocardial ischemia and reperfusion,” Circulation, vol. 91, no. 6, pp. 1872–1885, 1995. View at Scopus
7. J. Vasquez-Vivar, B. Kalyanaraman, and P. Martásek, “The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications,” Free Radical Research, vol. 37, no. 2, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
8. B. Lemmer and M. Arraj, “Effect of NO synthase inhibition on cardiovascular circadian rhythms in wild-type and eNOS-knock-out mice,” Chronobiology International, vol. 25, no. 4, pp. 501–510, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. T. S. Schmidt and N. J. Alp, “Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease,” Clinical Science, vol. 113, no. 1-2, pp. 47–63, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. J. Vasquez-Vivar, B. Kalyanaraman, N. Hogg, et al., “Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9220–9225, 1998. View at Publisher · View at Google Scholar · View at Scopus
11. J. Vasquez-Vivar, P. Martasek, J. Whitsett, J. Joseph, and B. Kalyanaraman, “The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study,” Biochemical Journal, vol. 362, no. 3, pp. 733–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
12. J. C.-W. Teng, H. Kay, Q. Chen, et al., “Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKCε) peptide activator or inhibitor in rat ischemia/reperfusion injury,” Naunyn-Schmiedebergs Archives of Pharmacology, vol. 378, no. 1, pp. 1–15, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. M. J. Crabtree, C. L. Smith, G. Lam, M. S. Goligorsky, and S. S. Gross, “Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS,” American Journal of Physiology, vol. 294, no. 4, pp. H1530–H1540, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. Z. Zhu, N. Takahashi, T. Ooie, T. Shinohara, K. Yamanaka, and T. Saikawa, “Oral administration of geranylgeranylacetone blunts the endothelial dysfunction induced by ischemia and reperfusion in the rat heart,” Journal of Cardiovascular Pharmacology, vol. 45, no. 6, pp. 555–562, 2005. View at Publisher · View at Google Scholar · View at Scopus
15. S. Yamashiro, K. Noguchi, Y. Kuniyoshi, K. Koja, and M. Sakanashi, “Role of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts,” Journal of Cardiovascular Surgery, vol. 44, no. 1, pp. 37–49, 2003. View at Scopus
16. J.-P. Guo, T. Murohara, M. Buerke, R. Scalia, and A. M. Lefer, “Direct measurement of nitric oxide release from vascular endothelial cells,” Journal of Applied Physiology, vol. 81, no. 2, pp. 774–779, 1996. View at Scopus
17. D. Omiyi, R. J. Brue, P. Taormina II, M. Harvey, N. Atkinson, and L. H. Young, “Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 2, pp. 542–551, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. M. V. Kuntscher, E. U. Schirmbeck, H. Menke, E. Klar, M. M. Gebhard, and G. Germann, “Ischemic preconditioning by brief extremity ischemia before flap ischemia in a rat model,” Plastic and Reconstructive Surgery, vol. 109, no. 7, pp. 2398–2404, 2002. View at Scopus
19. E. E. Peterman, P. Taormina II, M. Harvey, and L. H. Young, “Go 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion,” Journal of Cardiovascular Pharmacology, vol. 43, no. 5, pp. 645–656, 2004. View at Publisher · View at Google Scholar · View at Scopus
20. A. Phillipson, E. E. Peterman, P. Taormina, et al., “Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury,” American Journal of Physiology, vol. 289, no. 2, pp. H898–H907, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. D. J. Lefer, R. Scalia, B. Campbell, et al., “Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats,” Journal of Clinical Investigation, vol. 99, no. 4, pp. 684–691, 1997. View at Scopus
22. L. H. Young, Y. Ikeda, R. Scalia, and A. M. Lefer, “C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion,” American Journal of Physiology, vol. 279, no. 4, pp. H1453–H1459, 2000. View at Scopus
23. Y. Shi, P. Rafiee, J. Su, K. A. Pritchard, J. S. Tweddell, and J. E. Baker, “Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels,” Basic Research in Cardiology, vol. 99, no. 3, pp. 173–182, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. C. J. Zambrano, S. Krass, Q. Chen, K.-A. Perkins, B. Rueter, and L. H. Young, “Real time measurement of hydrogen peroxide (${\text{H}}_2$${\text{O}}_2$) or nitric oxide (NO) in femoral ischemia/reperfusion (I/R): effects of protein kinase C (PKC) epsilon activator ($\epsilon +$) or inhibitor ($\epsilon -$) combined with tetrahydrobiopterin (${\text{BH}}_4$) or dihydrobiopterin (${\text{BH}}_2$),” The FASEB Journal, vol. 23, pp. 617–619, 2009, abstract 617.19.
25. K. A. Perkins, S. Pershad, Q. Chen, S. McGraw, J. Adams, and L. H. Young, “Mechanisms related to endothelial nitric oxide synthase (eNOS) uncoupling in myocardial ischemia/reperfusion (MI/R),” The FASEB Journal, vol. 23, no. 4, pp. 793–522, 2009, abstract 793.13.
26. T. Koyanagi, K. Noguchi, A. Ootani, K. Inagaki, R. C. Robbins, and D. Mochly-Rosen, “Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model,” Journal of Molecular and Cellular Cardiology, vol. 43, no. 4, pp. 517–522, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus